Table 1 Demographic and baseline clinical characteristics
Variable | Overall | Group 1 total (n =) | Group 2 total (n =) |
|---|---|---|---|
Tracheal suction (n =) | Forced expiratory technique (n =), induced sputum (n =) | ||
Site | |||
Aabenraa | |||
Sønderborg | |||
Sex, n (%) | |||
Age, mean (SD) | |||
Smoking status | |||
Current smokers, n (%) | |||
Ex-smokers, n (%) | |||
Non-smokers, n (%) | |||
Symptoms | |||
Cough, n (%) | |||
Expectoration, n (%) | |||
Chest tightness, n (%) | |||
Dyspnea, n (%) | |||
Severity assessment | |||
CURB-65 score* 0–1, n (%) | |||
CURB-65 score* 2, n (%) | |||
CURB-65 score* 3–5, n (%) | |||
PSI* risk class 2–3, n (%) | |||
PSI* risk class 4, n (%) | |||
PSI* risk class 5, n (%) | |||
Triage level 1, n (%) | |||
Triage level 2–3, n (%) | |||
Triage level 4–5, n (%) | |||
Diagnostic packages | |||
Airways symptoms, n (%) | |||
Fever, n (%) | |||
Dyspnea, n (%) | |||
Unspecific illness, n (%) | |||
Suspicion of COVID-19 infection, n (%) | |||
Other, n (%) | |||
Suspicion of pneumonia, n (%) | |||
SARS-COV-2 positive at admission, n (%) | |||
Comorbidities | |||
COPD*, n (%) | |||
Asthma, n (%) | |||
DM*, n (%) | |||
CVD*, n (%) | |||
Cancer, n (%) | |||
Other, n (%) | |||
Vital parameters | |||
SaO2*, mean (SD) | |||
RR*, median (IQR) | |||
HR*, median (IQR) | |||
Systolic blood pressure, median (IQR) | |||
Diastolic blood pressure, median (IQR) | |||
Fever > 38 °C, n (%) | |||
Altered mental status, n (%) | |||
Blood tests | |||
C-reactive protein, mean (SD) | |||
Leucocytes, mean (SD) | |||
Neutrophils, mean (SD) | |||
Did the patient receive antibiotic treatment | |||
Within 1 month, n (%) | |||
Before sputum collection, n (%) | |||
Inhaled medications, n (%) | |||
Length of hospital stay, mean (SD) |